Compare HFBL & IINN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HFBL | IINN |
|---|---|---|
| Founded | 1924 | 2018 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.6M | 35.3M |
| IPO Year | N/A | 2021 |
| Metric | HFBL | IINN |
|---|---|---|
| Price | $15.99 | $1.10 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $2.00 |
| AVG Volume (30 Days) | 2.9K | ★ 134.1K |
| Earning Date | 10-23-2025 | 10-01-2025 |
| Dividend Yield | ★ 3.38% | N/A |
| EPS Growth | ★ 35.20 | N/A |
| EPS | ★ 1.47 | N/A |
| Revenue | ★ $21,720,000.00 | $289,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2,582.74 |
| P/E Ratio | $10.89 | ★ N/A |
| Revenue Growth | ★ 10.10 | N/A |
| 52 Week Low | $12.30 | $0.40 |
| 52 Week High | $16.95 | $1.65 |
| Indicator | HFBL | IINN |
|---|---|---|
| Relative Strength Index (RSI) | 59.69 | 57.17 |
| Support Level | $15.61 | $1.03 |
| Resistance Level | $16.10 | $1.19 |
| Average True Range (ATR) | 0.14 | 0.07 |
| MACD | -0.04 | 0.02 |
| Stochastic Oscillator | 43.53 | 72.40 |
Home Federal Bancorp Inc of louisiana operates as a bank holding company. It is a federally chartered stock savings bank, which provides financial services to individuals, corporate entities, and other organizations. Its core activities consist of attracting deposits from the general public and using those funds to originate loans to the residential, commercial and multi-family segments. The company also invests securities held-to-maturity and securities available for sale.
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. The respiratory care devices market is segmented geographically into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.